Moma Therapeutics
Clinical trials sponsored by Moma Therapeutics, explained in plain language.
-
New cancer pill targets genetic weakness in tumors
Disease control Recruiting nowThis early-stage trial is testing a new oral medication called MOMA-313, given alone or with an existing cancer drug (olaparib), in people with advanced solid tumors that have stopped responding to other treatments. The main goal is to find safe dose levels and see how the body p…
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for tough cancers: first human trial of experimental pill begins
Disease control Recruiting nowThis is the first human study testing a new oral drug called MOMA-341 for people with advanced solid tumors that have specific genetic features (MSI-H or dMMR). The main goal is to find safe doses and see how the body handles the drug when taken alone or combined with other cance…
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC